 Aaron Knox
Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keratin-5 | 1 | 2014 | 46 | 0.460 |
Why?
| | Receptors, Progesterone | 1 | 2014 | 319 | 0.400 |
Why?
| | Receptors, Estrogen | 1 | 2014 | 371 | 0.380 |
Why?
| | Pituitary Neoplasms | 5 | 2015 | 156 | 0.360 |
Why?
| | Phosphoribosylglycinamide Formyltransferase | 1 | 2008 | 1 | 0.320 |
Why?
| | Purines | 1 | 2008 | 158 | 0.290 |
Why?
| | Models, Biological | 1 | 2014 | 1611 | 0.280 |
Why?
| | Gonadotrophs | 4 | 2015 | 21 | 0.240 |
Why?
| | Breast Neoplasms | 1 | 2014 | 1846 | 0.210 |
Why?
| | raf Kinases | 1 | 2021 | 10 | 0.200 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 271 | 0.170 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2021 | 176 | 0.170 |
Why?
| | Pituitary Gland | 3 | 2015 | 147 | 0.160 |
Why?
| | Glioma | 1 | 2021 | 285 | 0.150 |
Why?
| | Adenoma | 2 | 2011 | 187 | 0.150 |
Why?
| | Mutation | 1 | 2008 | 3338 | 0.150 |
Why?
| | Gene Expression Regulation, Neoplastic | 4 | 2015 | 1142 | 0.120 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 35 | 0.120 |
Why?
| | MCF-7 Cells | 1 | 2014 | 105 | 0.110 |
Why?
| | Brain Neoplasms | 1 | 2021 | 966 | 0.110 |
Why?
| | Heterografts | 1 | 2014 | 117 | 0.110 |
Why?
| | Intercellular Adhesion Molecule-1 | 1 | 2014 | 147 | 0.110 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2014 | 181 | 0.110 |
Why?
| | Small Molecule Libraries | 1 | 2014 | 79 | 0.110 |
Why?
| | Immunophenotyping | 1 | 2014 | 274 | 0.110 |
Why?
| | Cell Proliferation | 4 | 2015 | 2173 | 0.100 |
Why?
| | Prolactinoma | 1 | 2011 | 11 | 0.100 |
Why?
| | Antigens, Differentiation | 1 | 2011 | 79 | 0.090 |
Why?
| | ErbB Receptors | 1 | 2014 | 554 | 0.090 |
Why?
| | Ki-67 Antigen | 1 | 2011 | 102 | 0.090 |
Why?
| | Gene Expression Profiling | 2 | 2014 | 1519 | 0.090 |
Why?
| | Cell Line, Tumor | 2 | 2014 | 2698 | 0.090 |
Why?
| | Glycoproteins | 1 | 2012 | 304 | 0.090 |
Why?
| | Oligonucleotide Array Sequence Analysis | 4 | 2015 | 742 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2014 | 677 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 1 | 2011 | 283 | 0.080 |
Why?
| | Cricetulus | 1 | 2008 | 97 | 0.080 |
Why?
| | Blotting, Northern | 1 | 2008 | 193 | 0.080 |
Why?
| | CHO Cells | 1 | 2008 | 137 | 0.080 |
Why?
| | Biocatalysis | 1 | 2008 | 58 | 0.080 |
Why?
| | Cell Cycle Proteins | 1 | 2012 | 549 | 0.080 |
Why?
| | Cricetinae | 1 | 2008 | 252 | 0.080 |
Why?
| | DNA, Complementary | 1 | 2008 | 255 | 0.080 |
Why?
| | Gene Dosage | 1 | 2008 | 129 | 0.070 |
Why?
| | DNA-Binding Proteins | 1 | 2014 | 1311 | 0.070 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2011 | 445 | 0.070 |
Why?
| | Cloning, Molecular | 1 | 2008 | 522 | 0.070 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2008 | 270 | 0.070 |
Why?
| | Animals | 7 | 2014 | 31565 | 0.070 |
Why?
| | Transfection | 1 | 2008 | 863 | 0.070 |
Why?
| | Genome | 1 | 2008 | 270 | 0.070 |
Why?
| | Mice | 5 | 2014 | 14841 | 0.070 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2008 | 388 | 0.070 |
Why?
| | Blotting, Western | 1 | 2008 | 1143 | 0.060 |
Why?
| | Up-Regulation | 3 | 2015 | 802 | 0.060 |
Why?
| | Sequence Analysis, DNA | 1 | 2008 | 722 | 0.060 |
Why?
| | Cystathionine beta-Synthase | 1 | 2006 | 59 | 0.060 |
Why?
| | RNA, Messenger | 2 | 2011 | 2550 | 0.060 |
Why?
| | Disease Models, Animal | 1 | 2014 | 3498 | 0.060 |
Why?
| | Cell Survival | 3 | 2015 | 1014 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2014 | 924 | 0.060 |
Why?
| | Biomarkers | 1 | 2014 | 3397 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 2783 | 0.060 |
Why?
| | Down Syndrome | 1 | 2006 | 335 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2006 | 1947 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2014 | 1624 | 0.040 |
Why?
| | Humans | 9 | 2021 | 114043 | 0.040 |
Why?
| | Female | 4 | 2021 | 59325 | 0.030 |
Why?
| | Cell Line | 2 | 2012 | 2629 | 0.030 |
Why?
| | Tumor Stem Cell Assay | 1 | 2015 | 33 | 0.030 |
Why?
| | Cytoprotection | 1 | 2015 | 51 | 0.030 |
Why?
| | Mutant Proteins | 1 | 2015 | 95 | 0.030 |
Why?
| | Gene Amplification | 1 | 2015 | 95 | 0.030 |
Why?
| | E-Selectin | 1 | 2014 | 52 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 2014 | 89 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2015 | 153 | 0.030 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 249 | 0.030 |
Why?
| | Immunoblotting | 1 | 2014 | 282 | 0.030 |
Why?
| | Cell Hypoxia | 1 | 2015 | 221 | 0.030 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 250 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2014 | 426 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 393 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2015 | 397 | 0.030 |
Why?
| | RNA Interference | 1 | 2014 | 431 | 0.030 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 796 | 0.030 |
Why?
| | G2 Phase | 1 | 2012 | 31 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2014 | 523 | 0.020 |
Why?
| | Genes, Tumor Suppressor | 1 | 2012 | 77 | 0.020 |
Why?
| | CpG Islands | 1 | 2012 | 118 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2012 | 109 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2015 | 379 | 0.020 |
Why?
| | Cavernous Sinus | 1 | 2011 | 14 | 0.020 |
Why?
| | Mitotic Index | 1 | 2011 | 26 | 0.020 |
Why?
| | Cytoplasm | 1 | 2012 | 255 | 0.020 |
Why?
| | Skull Base | 1 | 2011 | 39 | 0.020 |
Why?
| | Genes, p53 | 1 | 2011 | 61 | 0.020 |
Why?
| | NF-kappa B | 1 | 2014 | 636 | 0.020 |
Why?
| | Tumor Burden | 1 | 2011 | 258 | 0.020 |
Why?
| | Cell Division | 1 | 2012 | 754 | 0.020 |
Why?
| | Male | 4 | 2021 | 55396 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2011 | 438 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1128 | 0.020 |
Why?
| | Gene Expression | 1 | 2014 | 1417 | 0.020 |
Why?
| | Signal Transduction | 2 | 2015 | 4501 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 990 | 0.020 |
Why?
| | Gonadotropins, Pituitary | 1 | 2008 | 22 | 0.020 |
Why?
| | DNA Damage | 1 | 2011 | 351 | 0.020 |
Why?
| | Radiography | 1 | 2011 | 803 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2012 | 1131 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2008 | 845 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2008 | 347 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2014 | 3861 | 0.020 |
Why?
| | Diploidy | 1 | 2006 | 11 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2011 | 850 | 0.020 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2006 | 31 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2008 | 367 | 0.020 |
Why?
| | Apoptosis | 1 | 2015 | 2349 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2014 | 4680 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2006 | 308 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2464 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 17800 | 0.010 |
Why?
| | Aged | 2 | 2011 | 18969 | 0.010 |
Why?
| | Child | 1 | 2021 | 18400 | 0.010 |
Why?
| | Cognition Disorders | 1 | 2006 | 476 | 0.010 |
Why?
| | Middle Aged | 2 | 2011 | 26605 | 0.010 |
Why?
| | Time Factors | 1 | 2011 | 6077 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2011 | 6306 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2011 | 3039 | 0.010 |
Why?
| | Adult | 2 | 2011 | 30375 | 0.010 |
Why?
| | DNA | 1 | 2006 | 1350 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2011 | 9049 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2011 | 12521 | 0.010 |
Why?
|
|
Knox's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|